Carter's (CRI)
(Delayed Data from NYSE)
$61.59 USD
-0.15 (-0.24%)
Updated Jul 5, 2024 04:00 PM ET
After-Market: $61.58 -0.01 (-0.02%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$61.59 USD
-0.15 (-0.24%)
Updated Jul 5, 2024 04:00 PM ET
After-Market: $61.58 -0.01 (-0.02%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth B Momentum B VGM
Zacks News
Zacks Industry Outlook Highlights Adidas, Skechers, Caleres and Wolverine World Wide
by Zacks Equity Research
Adidas, Skechers, Caleres and Wolverine World Wide are part of the Zacks Industry Outlook article.
Carter's (CRI) Stock Dips 23% in 3 Months: What You Should Know
by Zacks Equity Research
Carter's (CRI) is battling with various uncertainties such as troubles in the business environment, inflation, generational high interest rates, higher consumer debt levels and recession risks.
Nike (NKE) Beats Q4 Earnings Estimates
by Zacks Equity Research
Nike (NKE) delivered earnings and revenue surprises of 18.82% and 2.13%, respectively, for the quarter ended May 2024. Do the numbers hold clues to what lies ahead for the stock?
Carter's (CRI) Gains From Robust Strategies Amid Inflation Woes
by Zacks Equity Research
Carter's (CRI) pricing strategy, efficient inventory management and enhanced product offerings have been driving growth amid the ongoing unfavorable impact of inflation.
Carter's (CRI) Q1 Earnings Improve Y/Y, Sales Decline 4.9%
by Zacks Equity Research
Carter's (CRI) experiences higher and earlier-than-expected demand from its largest wholesale customers in Q1.
Carter's (CRI) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Carter's (CRI) have what it takes? Let's find out.
Here's How Carter's (CRI) is Placed Ahead of Q1 Earnings
by Zacks Equity Research
Carter's (CRI) first-quarter 2024 results are likely to reflect inflationary impacts and increased performance-based compensation provisions.
Here's Why Carter's (CRI) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Carter's (CRI) have what it takes? Let's find out.
Why Carter's (CRI) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Is Carter's (CRI) Up 1.5% Since Last Earnings Report?
by Zacks Equity Research
Carter's (CRI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Carter's (CRI) Stock Looks Well Poised for Growth
by Zacks Equity Research
Carter's (CRI) strategic efforts are on track. The company is gaining from pricing strategy, inventory management efforts and improved product offerings.
Why Carter's (CRI) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Carter's (CRI) have what it takes? Let's find out.
Why Carter's (CRI) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Carter's (CRI) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Carter's (CRI) have what it takes? Let's find out.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Carter's (CRI) Strategic Efforts Bode Well: Apt to Hold
by Zacks Equity Research
Carter's (CRI) strategic efforts are on track. The company is gaining from pricing strategy, inventory management efforts and improved product offerings.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Carter's (CRI) Q4 Earnings Surpass Estimates, Sales Decline Y/Y
by Zacks Equity Research
Carter's (CRI) posts mixed fourth-quarter 2023 results, wherein the bottom line beat the Zacks Consensus Estimate while the top line missed.
Carter's (CRI) Tops Q4 Earnings Estimates
by Zacks Equity Research
Carter's (CRI) delivered earnings and revenue surprises of 9.52% and 0.85%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Why Carter's (CRI) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Carter's (CRI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Carter's (CRI) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Carter's (CRI) fourth-quarter 2023 results are likely to reflect higher-than-planned demand in its wholesale business and inflationary impacts.
Are Consumer Discretionary Stocks Lagging American Public Education (APEI) This Year?
by Zacks Equity Research
Here is how American Public Education (APEI) and Carter's (CRI) have performed compared to their sector so far this year.
Steven Madden (SHOO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Steven Madden (SHOO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.